SENSORY MIXABILITY PREFERENCE EVALUATION OF CHOLESTYRAMINE POWDER FORMULATIONS

被引：5

作者：

SHAEFER, MS

JUNGNICKEL, PW

MIWA, LJ

MARQUIS, NR

HUTTON, GD

机构：

[1] BRISTOL MYERS US PHARMACEUT GRP,EVANSVILLE,IN

[2] UNIV WASHINGTON,SEATTLE,WA 98195

来源：

DICP-THE ANNALS OF PHARMACOTHERAPY | 1990年 / 24卷 / 05期

关键词：

D O I：

10.1177/106002809002400507

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：472 / 474

页数：3

共 6 条

[1] LIPID-LOWERING DRUGS - AN OVERVIEW OF INDICATIONS AND OPTIMUM THERAPEUTIC USE [J].

ILLINGWORTH, DR .

DRUGS, 1987, 33 (03) :259-279

[2] THE INFLUENCE OF CHANGES IN LIPID VALUES INDUCED BY CHOLESTYRAMINE AND DIET ON PROGRESSION OF CORONARY-ARTERY DISEASE - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY [J].

LEVY, RI ;

BRENSIKE, JF ;

EPSTEIN, SE ;

KELSEY, SF ;

PASSAMANI, ER ;

RICHARDSON, JM ;

LOH, IK ;

STONE, NJ ;

ALDRICH, RF ;

BATTAGLINI, JW ;

MORIARTY, DJ ;

FISHER, ML ;

FRIEDMAN, L ;

FRIEDEWALD, W ;

DETRE, KM .

CIRCULATION, 1984, 69 (02) :325-337

[3]

SHAEFER MS, 1987, CLIN PHARMACY, V6, P51

[4]

1988, ARCH INTERN MED, V148, P36

[5]

1984, JAMA-J AM MED ASSOC, V251, P365

[6]

1984, JAMA-J AM MED ASSOC, V251, P351

← 1 →